CAR7, has shown remarkable success in reversing an aggressive form of leukemia. This world-first treatment uses gene ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

Measuring the lymphocytes - white blood cells that fight infection - in a patient's blood can be used to predict outcomes in ...

Immune therapy linvoseltamab showed deep early responses in multiple myeloma, raising hopes some patients may avoid bone ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.

A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...

Innovative therapy gives hope to patients whose blood cancer ‘seemed incurable’ - Almost two thirds of patients with T-cell ...

The U.S. Food and Drug Administration announced the approval of the first hematopoietic stem cell transplant therapy to treat ...

In a recent preclinical study, researchers from The University of Texas MD Anderson Cancer Center developed an antibody ...

Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive ...

People with cancer receiving immunotherapy earlier in the day survived longer, suggesting that adjusting treatment timing may ...

A new study suggests treatment-resistant depression may be rooted in the immune system. Trauma, stress biology, and mini-brain models reveal a hidden neuroimmune story.